Cargando…

c-Jun overexpression in CAR T cells induces exhaustion resistance

CAR T cells mediate antitumor effects in a small subset of cancer patients(1–3), but dysfunction due to T cell exhaustion is an important barrier to progress(4–6). To investigate the biology of exhaustion in human T cells expressing CAR receptors, we used a model system employing a tonically signali...

Descripción completa

Detalles Bibliográficos
Autores principales: Lynn, Rachel C., Weber, Evan W., Sotillo, Elena, Gennert, David, Xu, Peng, Good, Zinaida, Anbunathan, Hima, Lattin, John, Jones, Robert, Tieu, Victor, Nagaraja, Surya, Granja, Jeffrey, DeBourcy, Charles, Majzner, Robbie, Satpathy, Ansuman T., Quake, Stephen R., Monje, Michelle, Chang, Howard, Mackall, Crystal L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944329/
https://www.ncbi.nlm.nih.gov/pubmed/31802004
http://dx.doi.org/10.1038/s41586-019-1805-z
Descripción
Sumario:CAR T cells mediate antitumor effects in a small subset of cancer patients(1–3), but dysfunction due to T cell exhaustion is an important barrier to progress(4–6). To investigate the biology of exhaustion in human T cells expressing CAR receptors, we used a model system employing a tonically signaling CAR, which induces hallmark features of exhaustion(6). Exhaustion was associated with a profound defect in IL-2 production alongside increased chromatin accessibility of AP-1 transcription factor motifs and overexpression of bZIP and IRF transcription factors that have been implicated in mediating the dysfunctional program present in exhausted cells(7–10). Here we demonstrate that engineering CAR T cells to overexpress c-Jun, a canonical AP-1 factor, enhanced expansion potential, increased functional capacity, diminished terminal differentiation and improved antitumor potency in five different in vivo tumor models. We conclude that a functional deficiency in c-Jun mediates dysfunction in exhausted human T cells and that engineering CAR T cells to overexpress c-Jun renders them exhaustion-resistant, thereby addressing a major barrier to progress for this emerging class of therapeutics.